Stem cell bank is planned to be created at the Center for Advanced Technologies with the participation of the Research Institute of Hematology and Blood Transfusion, the Ministry of Innovation said in a statement.
The bank register will provide information on the availability of stem cell samples for transplantation to patients suffering from oncological diseases, impaired hematopoiesis, anemia, radiation sickness and other serious diseases.
The ministry added that future breakthroughs of evidence-based scientific medicine in the treatment of cancer, neurodegenerative, hereditary and cardiovascular diseases are now associated with stem cells.
Over the past two years, the experts of the Research Institute of Hematology and Blood Transfusions have successfully transplanted the healthy bone marrow stem cells from the peripheral blood of patients suffering from lymphoma and myeloma.
In the case of acute forms of leukemia, when the patient’s own bone marrow is damaged, it becomes necessary to select a related or antigen-compatible donor of bone marrow stem cells in each particular case. "And this results in losing precious time for a patient," – the statement added.
An alternative source of hematopoietic stem cells is umbilical cord blood. Cord blood sampling is carried out after childbirth, the technology is absolutely safe, painless and is accessible compared to the procedure for obtaining donor hematopoietic stem cells from bone marrow and peripheral blood, the ministry noted.
